Page 29 - Crispr News Today

The MoEFCC's recent decision to exclude new-gen GM plants from the ambit of existing biosafety rules endangers our food system, food exports, farmers' rights over their crops and the country's biological heritage for the sake of corporate profits.

Jiankuis widely condemned 2018 research was a key event in the murky ethical minefield of genetic modification.

Well-known medical professional Dr. Jane Ruby warned the public that gene editing therapy is dangerous and damaging to the human body. "It's so incredibly dangerous. Gene editing is [...]

DUBLIN, April 7, 2022 /PRNewswire/ -- ERS Genomics Limited (ERS) is pleased to announce a license agreement with Central Institute for Experimental Animals (CIEA) in Japan. This is a non-exclusive

Although it has been reported on by Igor Chudov a few days ago, I would like to add a bit more beef to this uncorroborated (so far) information, as it is the news no one wants to believe, but it [...]

Update: A Chinese biophysicist jailed in China for his role in helping to create the world's first gene-edited babies is a free man once more. The release of He Jiankui,...

Interview i did this with money. i needed the top fifty financial people that started with nothing about ray dalessio, carl icahn, warren buffett. e, i wrote a whole book on that. its like im going to give you one hundred and fifty of the best scientist nobel laureates rejected medicine doctors and show people this cutting edge material is coming apart. theres stuff nowck that curing diseases like with crispr like im a young man with on americas got talent, it was blind. you can see now or give ...

The Department of Health and Human Services (HHS) recently released the Food and Drug Administration (FDA) draft guidance for human gene therapy products. Entitled "Human Gene Therapy [...]

Researchers at InBio (formerly Indoor Biotechnologies), a biotech company in Virginia, report progress en route to developing a hypoallergenic cat – or at least treating patients with allergies to the domestic cat – in a new article published online in The CRISPR Journal.

Researchers from the biotech company InBio have employed CRISPR to successfully uncover an effective way to inhibit the most common source of cat allergies.